Lung-innervating nociceptor sensory neurons suppresses Ly6chi monocyte responses to promote pneumonic sepsis
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R21AI186057-01A1
Grant search
Key facts
Disease
Bacterial infection caused by Klebsiella pneumoniaStart & end year
20242026Known Financial Commitments (USD)
$228,000Funder
National Institutes of Health (NIH)Principal Investigator
ASSOCIATE PROFESSOR Pankaj BaralResearch Location
United States of AmericaLead Research Institution
KANSAS STATE UNIVERSITYResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY Carbapenem-resistant Klebsiella pneumoniae (CRKP) causes Gram-negative lung infections and fatal pneumonia-derived sepsis (or pneumonic sepsis) for which minimal treatment options are available. Importantly, CRKP-mediated pneumonia and sepsis is associated with immune suppression, rapid bacterial dissemination, and high mortality rate (20-40%) among the hospitalized patients. Host targeted alternative therapeutic approaches are thus necessary for pneumonic sepsis. The respiratory tract is densely innervated by nociceptor sensory neurons that mediate cough and bronchoconstriction and release of neuropeptides in the lungs, including calcitonin gene-related peptide (CGRP). Further, the released CGRP acts on its receptor complex (RAMP1/CALCRL) expressed in immune cells for immunomodulation. However, it is yet unknown the role of nociceptor neurons and CGRP in host defenses to Gram-negative pneumonia and pneumonic sepsis. Specifically, this research project will address the following two key questions: 1) Do nociceptor neurons and their subsets play role to alter the host CRKP clearance abilities and survival in pneumonic sepsis 2) Does neuropeptide signaling involve in driving pneumonic sepsis? Using both 'loss and gain of function' neuronal manipulating strategies in mice and using the nociceptor-targeted pharmacologic approach and neuropeptide- and neuropeptide receptor-deficient mice, this study will determine the role of neuroimmune interactions in pneumonic sepsis to address these questions. The preliminary in vivo and in vitro data demonstrate the host deleterious effects of nociceptor neurons and the CGRP signaling pathway for the defense against CRKP-induced pneumonic sepsis. Furthermore, the nociceptor-depleted mice showed higher CRKP clearance abilities and recruitment of neutrophils and inflammatory monocytes (Ly6Chi) at primary site of infection as compared to the control littermates. However, Ly6Chi monocytes were only observed to be critical for controlling CRKP dissemination. The proposed studies are significant and innovative because they identify neuroimmune crosstalk between nociceptors and innate immune cells as a novel mechanism to promote sepsis at both cellular and whole animal levels. Targeting the nervous system directly, or through downstream receptor signaling pathways in immune cells, will inform about the host-based strategy as a treatment modality for lethal Gram-negative infection and pneumonic sepsis.